Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
Michele P Lambert,1,2 1Division of Hematology, The Children's Hospital of Philadelphia, 2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Abstract: Pediatric data on the use of thrombopoietin ...
Lambert MP
core
Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA. [PDF]
Wang T +15 more
europepmc +1 more source
Cost-effectiveness analysis of eltrombopag, hetrombopag and romiplostim for second-line treatment of primary immune thrombocytopenia in China. [PDF]
Chen X, Liu Y, Zhang J, Xu R, Guo C.
europepmc +1 more source
Citation clarification regarding feline eltrombopag in the "ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats". [PDF]
Kim J, Kwak D.
europepmc +1 more source
Efficacy and safety of eltrombopag in the treatment of cancer therapy-induced thrombocytopenia: a large-scale, multicenter, retrospective study in China. [PDF]
Ding B +7 more
europepmc +1 more source
A Review of Thrombopoietin Receptor Agonists and Subsequent Development of Thrombosis: Exploring a Hematologic Paradox. [PDF]
Graifman G, Parekh R, C P RV, Nair A.
europepmc +1 more source
Update of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS). [PDF]
Gargano LP +10 more
europepmc +1 more source
Thrombopoietin receptor agonists in inherited thrombocytopenias: an evolving mosaic of evidence. [PDF]
Zaninetti C.
europepmc +1 more source
Eltrombopag use in surgical procedures in inherited thrombocytopenia: expanding the role of thrombopoietin-receptor agonists. [PDF]
Oliveira M +3 more
europepmc +1 more source
2026 Korean expert recommendations for the use of thrombopoietin receptor agonists in severe aplastic anemia. [PDF]
Park S +6 more
europepmc +1 more source

